MβCD59 (link), ezetimibe (Cayman Chemical Company, Ann Arbor, MI, USA), or DHA (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) treatments were modified from previous reports.
Free full text: Click here
Protocol detail
Cholesterol Modulation through Compounds
Corresponding Organization : Jichi Medical University
Other organizations : Chiba Institute of Science, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Top 5 similar protocols
Variable analysis
independent variables
- MβCD
- Ezetimibe
- Not explicitly mentioned
- Not explicitly mentioned
- No positive or negative controls were explicitly mentioned in the input.
Annotations
This protocol is too short. Unable to provide accurate annotations
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!